Prevalence, Glycemic Efficacy, and Safety of Four Non-Insulin Antidiabetic Drug Combinations in Patients with Type 2 Diabetes
In this study, 13.7% of patients with T2D received quadruple non-insulin drug combinations. Larger randomized controlled trials are needed to further evaluate their safety, efficacy, limitations, and potential role in T2D management.
Authors
- Gregory M. Dwyer
- Georgios S. Papaetis (ORCID: https://orcid.org/0000-0002-8143-7145)
- Anastasia Papapostolou (ORCID: https://orcid.org/0000-0002-6157-2761)
- Michalis K. Picolos
- Andriana M. Till
Institutions
- Alion Science and Technology (United States) (US)
- Cyprus University of Technology (CY)
- European University Cyprus (CY)
- Paphos General Hospital (CY)
- CDA College (CY)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2174/0118715303402479251129144029
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00